OpenVSafe by OpenVAERS
Search V-safe

23Z-20496-10195

2 vaccinations 11 coded responses 20 check-ins 11 free-text entries 6 call cases
Sex
Female
Age at first dose
36-40
ZIP prefix
971 / OR
Registered
2020-12-22
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Possible VAERS report

VAERS IDConfidenceScoreRunner-upShared symptomsDose StateVAERS vaccinated / onset / receivedCall case
1355011 (opens in a new window) high 11 / 11 3 7 of 10 VAERS symptoms same dose (2) OR matches 2021-01-10 / 2021-01-10 / 2021-05-27
received 54 days before the last call
case 845096

From the VAERS matching of call center cases (loader/vaers_match_*). Only the best match is shown, and only if it scores 8 or more out of 11. The score adds up timing (VAERS received soon after the call center contact), dose and shared symptoms; state only breaks ties. Confidence is high when the score is 8+ and at least 3 points ahead of the runner-up, medium when 5+ and 2 ahead, otherwise low. A match is a likely link, not a confirmed one.

Timeline

  1. 2020-12-22
    Registered in v-safe
  2. 2020-12-22
    Dose 1 — Pfizer-BioNTech
  3. 2020-12-22
    Survey response — day 0, dose 1
    MedDRA: Paraesthesia — Feeling: Good
    Free text: Tingling arms
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2020-12-26
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · Chills, Headache, Fatigue or tiredness, Nausea, Diarrhea · Be unable to do your normal daily activities
    Adult check-in
  5. 2020-12-26
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to do your normal daily activities
    1 call case(s)
  6. 2020-12-28
    Survey response — days 1–6 daily, dose 1
    MedDRA: Chest pain, Chills, Headache, Nausea, Pain, Pyrexia — Feeling: Fair · Site: Pain · Fatigue or tiredness, Nausea
    Free text: Never got check in during first few days, had fever 101.6, nausea, body aches, chills, chest pain, headache. I am a long hauler though so maybe accounts for more significant reaction
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2020-12-29
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-01-05
    Survey response — day 14, dose 1
    MedDRA: Chest pain, Nausea — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Chest pain, nausea
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  9. 2021-01-05
    Report sent to call center — day 14, dose 1
    Be unable to do your normal daily activities
    1 call case(s)
  10. 2021-01-10
    Dose 2 — Pfizer-BioNTech
  11. 2021-01-10
    Survey response — day 0, dose 2
    MedDRA: Dizziness, Feeling hot — Feeling: Fair · Site: Pain, Itching
    Free text: Dizzy and hot
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  12. 2021-01-11
    Survey response — days 1–6 daily, dose 2
    MedDRA: Chest pain — Feeling: Poor · Site: Pain, Itching · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Free text: Chest pain
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  13. 2021-01-11
    Report sent to call center — days 1–6 daily, dose 2
    Be unable to do your normal daily activities
    1 call case(s)
  14. 2021-01-12
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea
    Adult check-in
  15. 2021-01-13
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain, Itching · Headache, Fatigue or tiredness, Nausea, Rash, not including the immediate area around the injection site
    Adult check-in
  16. 2021-01-15
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Itching · Chills, Muscle or body aches, Fatigue or tiredness, Diarrhea
    Adult check-in
  17. 2021-01-16
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Headache, Fatigue or tiredness
    Adult check-in
  18. 2021-01-17
    Survey response — day 7, dose 2
    MedDRA: Chest pain — Feeling: Fair · Headache, Fatigue or tiredness
    Free text: Chest pain-cardiac
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  19. 2021-01-24
    Survey response — day 14, dose 2
    MedDRA: Diarrhoea, Nausea — Feeling: Fair
    Free text: Nausea, diarrhea
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  20. 2021-02-02
    Survey response — day 21, dose 2
    MedDRA: Angina pectoris, Palpitations, Paraesthesia, Rhinorrhoea, Tachycardia — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Cardiac pain, tachycardia, palpitations, tingling extremities, runny nose.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  21. 2021-02-02
    Report sent to call center — day 21, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  22. 2021-02-07
    Health check-in — day 28, dose 2
    Feeling: Fair
    Adult check-in
  23. 2021-02-14
    Health check-in — day 35, dose 2
    Feeling: Fair
    Adult check-in
  24. 2021-02-21
    Health check-in — day 42, dose 2
    Feeling: Fair
    Adult check-in
  25. 2021-04-13
    Survey response — 3 months, dose 2
    MedDRA: Night sweats — Feeling: Fair
    Free text: Night sweats
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  26. 2021-05-19
  27. 2021-05-27
  28. 2021-05-27
    Call successful
    Completed over the phone
  29. 2021-07-11
    Survey response — 6 months, dose 2
    MedDRA: Lung disorder, Obstructive airways disorder — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Obstructive lung disease
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  30. 2021-07-11
    Report sent to call center — 6 months, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  31. 2021-07-20
  32. 2022-01-10
    Survey response — 12 months, dose 2
    MedDRA: Chest pain, Confusional state, Hallucination, Pelvic mass — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Worsening chest pain, hallucinations, confusion, pelvic mass
    MedDRA releases: 2024-11 · check-in free text available
  33. 2022-01-10
    Report sent to call center — 12 months, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  34. 2022-01-11
    Call successful
    Reported to VAERS during previous contact from GDIT

Vaccinations

DoseDateManufacturerCo-administered
12020-12-22Pfizer-BioNTech
22021-01-10Pfizer-BioNTech

Call center

6 call center cases

3 successful · 3 priority 2/3 (triaged and no follow up)

VAERS report filed, before or during a call: 3

1 wait over 3 months for a first call

See the call center timeline

Free text

Release 1 — day 0, dose 1

2020-12-22

Systemic reaction (other): Tingling arms

Release 1 — days 1–6 daily, dose 1

2020-12-28

Systemic reaction (other): Never got check in during first few days, had fever 101.6, nausea, body aches, chills, chest pain, headache. I am a long hauler though so maybe accounts for more significant reaction

Release 1 — day 14, dose 1

2021-01-05

Symptoms: Chest pain, nausea

Release 1 — day 0, dose 2

2021-01-10

Systemic reaction (other): Dizzy and hot

Release 1 — days 1–6 daily, dose 2

2021-01-11

Systemic reaction (other): Chest pain

Release 2 — day 7, dose 2

2021-01-17

Systemic reaction (other): Chest pain-cardiac

Release 2 — day 14, dose 2

2021-01-24

Symptoms: Nausea, diarrhea

Release 3 — day 21, dose 2

2021-02-02

Symptoms: Cardiac pain, tachycardia, palpitations, tingling extremities, runny nose.

Release 7 — 3 months, dose 2

2021-04-13

Symptoms: Night sweats

Release 9 — 6 months, dose 2

2021-07-11

Symptoms: Obstructive lung disease

Release 10 — 12 months, dose 2

2022-01-10

Symptoms: Worsening chest pain, hallucinations, confusion, pelvic mass

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAngina pectoris ✓ ✓ ✓
SDChest pain ✓ ✓ ✓
SDConfusional state · · ✓
SDDiarrhoea ✓ ✓ ✓
SDHallucination · · ✓
SDLung disorder ○ ✓ ○
SDNausea ✓ ✓ ✓
SDNight sweats ✓ ✓ ✓
SDObstructive airways disorder ✓ · ✓
SDPalpitations ✓ ✓ ✓
SDParaesthesia ✓ ✓ ✓
SDPelvic mass · · ✓
SDRhinorrhoea ✓ ✓ ✓
SDTachycardia ✓ ✓ ✓
SROChest pain ✓ ✓ ✓
SROChills ✓ ✓ ✓
SRODizziness ✓ ✓ ✓
SROFeeling hot ✓ ✓ ✓
SROHeadache ✓ ✓ ✓
SRONausea ✓ ✓ ✓
SROPain ✓ ✓ ✓
SROParaesthesia ✓ ✓ ✓
SROPyrexia ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release